Trametinib 2mg Tablet (LuciTram) Price in Pakistan | Impo Medic
₨ 0
Description
Trametinib 2mg Tablet (LuciTram) Price in Pakistan
Trametinib 2mg Tablet (LuciTram) contains trametinib, a targeted cancer medicine classified as a MEK inhibitor. It works by blocking specific proteins involved in the MAPK signalling pathway, which can contribute to the growth and spread of certain cancer cells.
LuciTram 2mg is manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd. It is listed as a pack of 30 tablets and is intended for specialist-directed treatment of certain cancers with specific BRAF mutations.
Uses of Trametinib 2mg
Trametinib may be prescribed for eligible patients with:
- Unresectable or Metastatic Melanoma: Used for melanoma with BRAF V600E or V600K mutations. It may be prescribed alone in selected treatment-naïve patients or in combination with dabrafenib.
- Adjuvant Melanoma Treatment: Used with dabrafenib in eligible patients with BRAF-mutated melanoma following complete surgical resection.
- Non-Small Cell Lung Cancer (NSCLC): Used in combination with dabrafenib for certain advanced or metastatic cancers with a BRAF V600E mutation.
- Anaplastic Thyroid Cancer: May be used with dabrafenib in eligible patients with locally advanced or metastatic BRAF V600E-mutated disease when satisfactory local treatment options are unavailable.
Treatment suitability depends on the cancer diagnosis, mutation testing, previous treatment and applicable product approval.
How Trametinib Works
Trametinib selectively inhibits MEK1 and MEK2, proteins involved in the MAPK signalling pathway. This pathway helps regulate cell growth and division.
Certain cancers have mutations, including BRAF V600 mutations, that can cause this pathway to become overactive. By blocking MEK activity, trametinib helps slow abnormal cancer-cell growth and tumour progression.
It may be used alone or alongside dabrafenib, a BRAF inhibitor, depending on the cancer type and treatment plan.
Dosage and Administration
The dosage of Trametinib must be determined by an oncologist according to the patient’s diagnosis, treatment response and tolerance.
For adults with the relevant approved indications, the commonly recommended dose is 2mg once daily. The dose may differ in combination regimens or when treatment adjustments are required.
- Take the tablet orally once daily as prescribed.
- Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.
- Swallow the tablet whole with water.
- Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
- Take the medicine at approximately the same time each day.
- Do not change or stop treatment without consulting your oncologist.
Precautions
- Heart function: Trametinib may reduce the heart’s pumping ability. Cardiac function should be assessed before and during treatment.
- Eye problems: Retinal disorders and other visual complications may occur. Report blurred vision, visual changes or eye pain promptly.
- Lung complications: Interstitial lung disease or pneumonitis may occur and requires medical assessment.
- Bleeding: Serious haemorrhagic events have been reported. Report unusual or persistent bleeding.
- Blood clots: Patients should be monitored for symptoms of deep vein thrombosis or pulmonary embolism.
- Skin monitoring: Skin changes and new malignancies may occur, particularly when trametinib is combined with dabrafenib.
- Gastrointestinal complications: Colitis and gastrointestinal perforation are important potential risks.
- Pregnancy: Trametinib may harm an unborn baby. Discuss effective contraception and pregnancy precautions with your doctor.
- Breastfeeding: Breastfeeding should be avoided during treatment and for the period specified in the prescribing information.
- Medical history: Inform your doctor about heart disease, eye conditions, lung problems and all medicines being used.
Regular medical assessments and monitoring are essential throughout treatment.
Product Information
- Product Name: Trametinib 2mg Tablet
- Brand Name: LuciTram
- Generic Name: Trametinib
- Strength: 2mg
- Dosage Form: Tablet
- Pack Size: 30 Tablets
- Manufacturer: Lucius Pharmaceuticals (Lao) Co., Ltd.
- Country of Manufacture: Laos
FAQs About Trametinib 2mg Tablet (LuciTram) Price in Pakistan
What is Trametinib 2mg Tablet used for?
Trametinib is a targeted cancer medicine used for certain BRAF-mutated cancers, including selected cases of melanoma and non-small cell lung cancer.
What is LuciTram 2mg?
LuciTram 2mg is a branded trametinib tablet manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd.
How does Trametinib work?
It blocks MEK1 and MEK2 proteins in the MAPK signalling pathway, helping slow the growth of certain cancer cells.
Is Trametinib used with Dabrafenib?
Yes. Trametinib is commonly prescribed with dabrafenib for several BRAF-mutated cancer indications. The combination depends on the patient’s diagnosis and treatment plan.
What is the usual adult dose of Trametinib?
The commonly recommended adult dose for relevant approved indications is 2mg once daily. Only the treating oncologist should determine the appropriate dose.
Should Trametinib be taken with food?
No. It should generally be taken on an empty stomach, at least 1 hour before or 2 hours after a meal.
How many tablets are included in a LuciTram pack?
The listed LuciTram pack contains 30 tablets of Trametinib 2mg.
Does Trametinib require a prescription?
Yes. Trametinib is a specialist cancer medicine requiring an oncologist’s prescription and regular monitoring.
Trametinib 2mg in Pakistan
Customers searching for Trametinib 2mg Tablet (LuciTram) in Pakistan can contact Impo Medic for product information and order-related assistance. For queries about Trametinib 2mg price in Pakistan, LuciTram availability or imported trametinib tablets, product and supply details can be confirmed with the team. Prescription requirements apply.

Reviews
There are no reviews yet.